UBS Group Reaffirms Buy Rating for Dixons Carphone (LON:DC) – Mayfield Recorder
Dixons Carphone (LON:DC)‘s stock had its “buy” rating restated by research analysts at UBS Group in a report released on Thursday, June 20th, Digital Look reports. Royal Bank of Canada set a $184.00 target price on Jazz Pharmaceuticals and gave the company a “buy” rating in a research note on Monday, March 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. Dixons Carphone presently has a consensus rating of “Hold” and an average price target of GBX 165 ($2.16).